$0.8256
-0.06-6.99%
At close: -
$0.8212
-0.00440-0.53%
After Hours: 4:14 PM EDT
Comments
Loading...
Context Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:CNTX | Benzinga
Context Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 20
EPS Estimate
$-0.060
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Context Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Context Therapeutics (CNTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-06 | $-0.22 | $-0.09 | -144.4 % |
| Q2 | 2024-08-07 | $-0.04 | $-0.07 | 42.9 % |
| Q1 | 2024-05-08 | $-0.23 | $-0.38 | 39.5 % |
| Q4 | 2024-03-21 | $-0.42 | $-0.35 | -20.0 % |
Context Therapeutics (CNTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Context Therapeutics (NASDAQ:CNTX) reporting earnings?
Context Therapeutics (CNTX) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
What were the latest earnings per share (EPS) for Context Therapeutics (NASDAQ:CNTX)?
The Actual EPS was $-0.22, which missed the estimate of $-0.09.
What were Context Therapeutics’s (NASDAQ:CNTX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.